研究
教育
解決策
サインイン
JA
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Genitourinary Medical Oncology Research,
Division of Cancer Medicine,
Department of Genitourinary Medical Oncology Research, Division of Cancer Medicine
Peter Shepherd has not added Biography.
If you are Peter Shepherd and would like to personalize this page please email our Author Liaison for assistance.
Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition.
Oncogene 04, 2019 | Pubmed ID: 30532030
The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling.
Oncotarget Nov, 2018 | Pubmed ID: 30555629
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2020 | Pubmed ID: 32576626
The University of Texas MD Anderson Cancer Center
Lindsey K. Sablatura1,
Kristin M. Bircsak2,
Peter Shepherd3,
Karla Queiroz4,
Mary C. Farach-Carson1,5,6,
Pamela E. Constantinou1,7,
Anthony Saleh2,
Nora Navone3,
Daniel A. Harrington1,5,6
1Department of BioSciences, Rice University,
2, Mimetas US Inc,
3Department of Genitourinary Medical Oncology Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center,
4, Mimetas B.V.,
5Department of Bioengineering, Rice University,
6Department of Diagnostic and Biomedical Sciences, The University of Texas Health Science Center,
7Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center
個人情報保護方針
利用規約
一般データ保護規則
お問い合わせ
図書館への推薦
JoVE ニュースレター
JoVE Journal
メソッドコレクション
JoVE Encyclopedia of Experiments
アーカイブ
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教員向けリソースセンター
著者
図書館員
アクセス
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved